Bornali Bhattacharjee
Associate Research ScientistCards
About
Titles
Associate Research Scientist
Associate Director, Center for Infection and Immunity
Biography
Dr. Bornali Bhattacharjee, MS, PhD is a Research Associate Scientist at the Department of Immunobiology and the Associate Director at the Center for Infection & Immunity. Her role is to lead, coordinate and manage biomedical research projects that are geared towards understanding the immune trajectories of post-acute infection syndromes.
Her training and research interests lie at the interface of pathogen genomics, evolutionary biology and host-pathogen interaction. She earned her PhD in Molecular Epidemiology & Virology from Indian Statistical Institute & University of Calcutta. Her post-doctoral training was in Viral Genomics & Evolution at University of Massachusetts Medical School.
Last Updated on November 07, 2024.
Departments & Organizations
Education & Training
- PhD
- Indian Statistical Institute & University of Calcutta
- MS
- University of Calcutta, Biochemistry
Research
Publications
2026
A causal link between autoantibodies and neurological symptoms in long COVID
de Sá K, Silva J, Bayarri-Olmos R, Baker C, Lu Z, Gipson W, Na D, Chen B, Wenxue L, Khosroabadi D, Brinda R, Constable R, Omene B, Colom Díaz P, Kwon D, Rodrigues G, Heidecke H, Schulze-Forster K, Gross A, Shneer T, Clarke A, Linnekin T, Brate A, Brown L, Buda H, Jatiani S, Moise L, Greene K, Bhagchandani S, Bhattacharjee B, Gehlhausen J, Wood J, Tabacof L, Scheibenbogen C, Liu Y, Guan L, Schneeberger Pane M, Putrino D, Horvath T, Iwasaki A. A causal link between autoantibodies and neurological symptoms in long COVID. Cell 2026, 189: 3214-3235.e37. PMID: 42208499, DOI: 10.1016/j.cell.2026.04.042.Peer-Reviewed Original ResearchLong COVID and Recovery Among US Adults
Shah R, Shah K, Chen J, Sawano M, Bhattacharjee B, Krumholz H. Long COVID and Recovery Among US Adults. JAMA Network Open 2026, 9: e260374. PMID: 41770566, PMCID: PMC12954541, DOI: 10.1001/jamanetworkopen.2026.0374.Peer-Reviewed Original ResearchOcular Symptoms in Long COVID: A Cross-Sectional Study
Kaleem S, Sawano M, Arun A, Warner F, Zhou T, Huang C, Bhattacharjee B, Lu Y, Iwasaki A, Nwanyanwu K, Ahmed I, Krumholz H. Ocular Symptoms in Long COVID: A Cross-Sectional Study. Clinical Ophthalmology 2026, 20: 565596. PMID: 41907807, PMCID: PMC13024366, DOI: 10.2147/opth.s565596.Peer-Reviewed Original Research
2025
Characterization of Postural Orthostatic Tachycardia Syndrome in Long COVID Self-reported Data From the LISTEN Study
AL Mouslmani M, Sawano M, Arun A, Wu Y, Shah R, Kaleem S, Zhou T, Murugiah K, Lu Y, Herrin J, Bishop P, Taub P, Peixoto A, Bhattacharjee B, Iwasaki A, Krumholz H. Characterization of Postural Orthostatic Tachycardia Syndrome in Long COVID Self-reported Data From the LISTEN Study. JACC Advances 2025, 4: 101873. PMID: 40883051, PMCID: PMC12399260, DOI: 10.1016/j.jacadv.2025.101873.Peer-Reviewed Original ResearchCerebrospinal fluid immune phenotyping reveals distinct immunotypes of myalgic encephalomyelitis/chronic fatigue syndrome
Bastos V, Greene K, Tabachnikova A, Bhattacharjee B, Sjögren P, Bertilson B, Reifert J, Zhang M, Kamath K, Shon J, Gehlhausen J, Guan L, VanElzakker M, Proal A, Bragée B, Iwasaki A. Cerebrospinal fluid immune phenotyping reveals distinct immunotypes of myalgic encephalomyelitis/chronic fatigue syndrome. The Journal Of Immunology 2025, 214: 1539-1551. PMID: 40373264, PMCID: PMC12311384, DOI: 10.1093/jimmun/vkaf087.Peer-Reviewed Original ResearchImpact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naïve individuals with Long COVID
Grady C, Bhattacharjee B, Silva J, Jaycox J, Lee L, Silva Monteiro V, Sawano M, Massey D, Caraballo C, Gehlhausen J, Tabachnikova A, Mao T, Lucas C, Peña-Hernandez M, Xu L, Tzeng T, Takahashi T, Herrin J, Güthe D, Akrami A, Assaf G, Davis H, Harris K, McCorkell L, Schulz W, Griffin D, Wei H, Ring A, Guan L, Dela Cruz C, Krumholz H, Iwasaki A. Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naïve individuals with Long COVID. Communications Medicine 2025, 5: 163. PMID: 40346201, PMCID: PMC12064684, DOI: 10.1038/s43856-025-00829-3.Peer-Reviewed Original ResearchNirmatrelvir–ritonavir versus placebo–ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial
Sawano M, Bhattacharjee B, Caraballo C, Khera R, Li S, Herrin J, Christian D, Coppi A, Warner F, Holub J, Henriquez Y, Johnson M, Goddard T, Rocco E, Hummel A, Mouslmani M, Hooper W, Putrino D, Carr K, Charnas L, De Jesus M, Nepert D, Abreu P, Ziegler F, Spertus J, Iwasaki A, Krumholz H. Nirmatrelvir–ritonavir versus placebo–ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial. The Lancet Infectious Diseases 2025, 25: 936-946. PMID: 40188838, DOI: 10.1016/s1473-3099(25)00073-8.Peer-Reviewed Original Research
2024
Internal Tremors and Vibrations in Long COVID: A Cross-Sectional Study
Zhou T, Sawano M, Arun A, Caraballo C, Michelsen T, McAlpine L, Bhattacharjee B, Lu Y, Khera R, Huang C, Warner F, Herrin J, Iwasaki A, Krumholz H. Internal Tremors and Vibrations in Long COVID: A Cross-Sectional Study. The American Journal Of Medicine 2024, 138: 1010-1018.e14. PMID: 39069199, PMCID: PMC12023347, DOI: 10.1016/j.amjmed.2024.07.008.Peer-Reviewed Original ResearchThe PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-Blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVID
Krumholz H, Sawano M, Bhattacharjee B, Caraballo C, Khera R, Li S, Herrin J, Coppi A, Holub J, Henriquez Y, Johnson M, Goddard T, Rocco E, Hummel A, Al Mouslmani M, Putrino D, Carr K, Carvajal-Gonzalez S, Charnas L, De Jesus M, Ziegler F, Iwasaki A. The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-Blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVID. The American Journal Of Medicine 2024, 138: 884-892.e4. PMID: 38735354, DOI: 10.1016/j.amjmed.2024.04.030.Peer-Reviewed Original ResearchLong COVID Characteristics and Experience: A Descriptive Study From the Yale LISTEN Research Cohort
Sawano M, Wu Y, Shah R, Zhou T, Arun A, Khosla P, Kaleem S, Vashist A, Bhattacharjee B, Ding Q, Lu Y, Caraballo C, Warner F, Huang C, Herrin J, Putrino D, Michelsen T, Fisher L, Adinig C, Iwasaki A, Krumholz H. Long COVID Characteristics and Experience: A Descriptive Study From the Yale LISTEN Research Cohort. The American Journal Of Medicine 2024, 138: 712-720.e13. PMID: 38663793, DOI: 10.1016/j.amjmed.2024.04.015.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
Get In Touch
Contacts
Events
Oct 20269Friday
Everyone Akiko Iwasaki, PhD - Harlan Krumholz, MD, SM - Todd Constable, PhD - Lisa Sanders, MD, FACP - Ruslan Medzhitov, PhD - John S. Tsang, PhD, MMath - Catherine Dulac - Michal Caspi Tal - Meighan Stone